References
- Alexander RT, Dimke H. Effects of parathyroid hormone on renal tubular calcium and phosphate handling. Acta Physiol 238, e13959, 2023.
- Burtis CA, Bruns DE. Tietz fundamentals of clinical chemistry and molecular diagnostics-e-book. Elsevier Health Sciences, 2014.
- Calinski T, Steel R GD, Torrie JH. Principles and procedures of statistics: a biometrical approach. Biometrics 37, 859, 1981.
- Faron-Gorecka A, Latocha K, Pabian P, Kolasa M, Sobczyk-Krupiarz I, Dziedzicka-Wasylewska M. The involvement of prolactin in stress-related disorders. Int J Environ Res Public Health 20, 3257, 2023.
- Flores JM, Benfante N, Schofield E, Mulhall JP. PD47-04 analyzing the impact of testosterone on bone density loss. J Urol 207, e794, 2022.
- Gierach M, Bruska-Sikorska M, Rojek M, Junik R. Hyperprolactinemia and insulin resistance. Endokrynol Pol 73, 959–967, 2022.
- Haidenberg-David F, Sidauy-Adissi J, Moscona-Nissan A, Jonguitud-Zumaya E, Fugarolas-Morinelli M, Martinez- Mendoza F, Taniguchi-Ponciano K, Marrero-Rodriguez D, Mercado M. Overview of hyperprolactinemia: general approach and reproductive health implications. Arch Med Res 55, 103102, 2024.Han Y, Zhang H, Huang T, Wang F, Zhu Y. A retrospective study of pituitary-thyroid interaction in patients with first-episode of bipolar disorder type I in Mania State. Medicine 100, e24645, 2021.
- Kabootari M, Shirmohammadli H, Golgiri F, Mosalamiaghili S, Khajavi A, Akbari H. Metabolic effects of dopamine agonists treatment among patients with prolactinomas. Endocrine 79, 537–544, 2023.
- Korta K, Szeliga A, Oluszczak K, Szostak A, Dylag L, Wawszkowicz K, Szopinska K, Smigielska-Mikolajczyk MJ, Lowicka W, Graca M. The role of prolactin levels in metabolic syndrome: a systematic review. Quality Sport 22, 54607, 2024.
- Leung EKY. Parathyroid hormone. Adv Clin Chem 101, 41–93, 2021.
- Lombardi G, Ziemann E, Banfi G, Corbetta S. Physical activity-dependent regulation of parathyroid hormone and calcium-phosphorous metabolism. Int J Mol Sci 21, 5388, 2020.
- Loraine JA, Bell ET. Hormone assays and their clinical application. No 3rd Edition, 1971.
- Matikainen N, Pekkarinen T, Ryhanen E. M, Schalin-Jantti C. Physiology of calcium homeostasis. Endocrinol Metab Clin North Am 50, 575–590, 2021.
- Parak A, Daya R, Bulbulia S, Seedat F, Bayat Z. Hyperprolactinaemia in a patient with kidney failure. African J Nephrol 23, 172–174, 2020.
- Pirchio R, Graziadio C, Colao A, Pivonello R, Auriemma RS. Metabolic effects of prolactin. Front Endocrinol 13, 1015520, 2022.
- Roden M, Petersen KF, Shulman GI. Insulin resistance in type 2 diabetes. Textbook Diabetes 238–249, 2024.
- Sheoran A, Agarwal N, Mahto SK, Gupta PK, Gupta K, Sharma N. Study of association of serum prolactin levels with insulin resistance in type 2 diabetes mellitus patients. Indian J Endocrinol Metab 27, 351–356, 2023.
- Szulc P. Role of sex steroids hormones in the regulation of bone metabolism in men: evidence from clinical studies. Best Pract Res Clin Endocrinol Metab 36, 101624, 2022.
- Trost L. Hyperprolactinemia in men with testosterone deficiency. In Controversies in testosterone deficiency, 35–43. Cham: Springer International Publishing, 2021.
- Wang L, Wang X, Gong F, Pan H, Zhu H. Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. Front Endocrinol 14, 1285477, 2023.
- Yun YM, Botelho JC, Chandler DW, Katayev A, Roberts WL, Stanczyk FZ, Vesper HW, Nakamoto JM, Garibaldi L, Clarke NJ, Fitzgerald RL. Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the partnership for the accurate testing of hormones. Clin Chem 58, 1703–1710, 2012.
- Zaidalkilani AT, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Al-Farga A, Alghamdi OA, Bahaa MM, Alrouji M, Alshammari MS, El-Saber Batiha G. The beneficial and detrimental effects of prolactin hormone on metabolic syndrome: A double-edge sword. J Cell Mol Med 28, e70067, 2024.